欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4339/001
药品名称Granisetron Kabi 1mg/ml concentrate for solution for infusion
活性成分
    • granisetron 1.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人FRESENIUS KABI LIMITED
参考成员国 - 产品名称Netherlands (NL)
Granisetron Fresenius Kabi 1 mg/ml oplossing voor injectie
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 08828/0191 - 0005
    • Germany (DE)
      Granisetron Kabi 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Belgium (BE)
    • Luxembourg (LU)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Granisetron Fresenius Kabi
    • Finland (FI)
    • Czechia (CZ)
      Granisetron Kabi 1 mg/ml, koncentrát pro přípravu infuzního roztoku
    • Romania (RO)
      Granisetron Kabi 1 mg/ml concentrat pentru solutie injectabilă/perfuzabilă
    • Slovakia (SK)
      Granisetron Kabi 1mg/ ml, infúzny koncentrát
许可日期2008/11/21
最近更新日期2024/02/29
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase